Uday Kompella - 18 Oct 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Uday Kompella by Sanjay Subramanian, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
18 Oct 2021
Transactions value $
-$1,697,614
Form type
4
Filing time
20 Oct 2021, 18:57:29
Previous filing
30 Jul 2021
Next filing
22 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Sale -$1.68M -200K -41.72% $8.41* 279K 18 Oct 2021 By: Kompella LLC F1, F2
transaction OCGN Common Stock Sale -$15.6K -1.73K -0.62% $9.02* 278K 20 Oct 2021 By: Kompella LLC F1, F3
holding OCGN Common Stock 551K 18 Oct 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.12 to $8.81. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.03. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.